Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
Mon, 11/16/20 - 10:13 am
Tags:
AHA, Omecamtiv Mecarbil, Amgen, Cytokinetics, heart failure
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Fierce Pharma
Tue, 11/10/20 - 10:41 am
Tags:
Amgen, AstraZeneca, tezepelumab, asthma, severe asthma, clinical trials
Bristol Myers' psoriasis drug beats Amgen rival in phase 3
Fierce Biotech
Tue, 11/3/20 - 10:49 am
Tags:
Bristol-Myers Squibb, deucravacitinib, Amgen, Otezla, clinial trials, plaque psoriasis
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Motley Fool
Thu, 10/29/20 - 12:01 pm
Tags:
Amgen, earnings, Otezla
Amgen Reports Stronger-Than-Expected Q3 Earnings; Revenue Gains 12%
TheStreet.com
Wed, 10/28/20 - 11:19 pm
Tags:
Amgen
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Sun, 10/25/20 - 11:30 pm
Tags:
Mirati Therapeutics, Amgen, adagrasib, lung cancer
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Thu, 10/8/20 - 11:19 pm
Tags:
Amgen, Cytokinetics, Servier, clinical trials, Omecamtiv Mecarbil, cardiovascular disease
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Tue, 10/6/20 - 10:26 am
Tags:
Amgen, clinical trials, non-small cell lung cancer, KRAS, sotorasib
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
BioSpace
Mon, 10/5/20 - 11:43 am
Tags:
Amgen, Novartis, Aimovig, migraines, episodic migraines
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Fierce Pharma
Thu, 10/1/20 - 11:29 am
Tags:
congress, drug pricing, Novartis, Amgen, Mallinckrodt
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Fierce Pharma
Tue, 09/22/20 - 10:21 pm
Tags:
drug pricing, regulatory, Celgene, Bristol-Myers Squibb, Teva Pharmaceutical, Amgen, Novartis, Mallinckrodt, AbbVie, US Congress
Amgen publishes, presents data on therapy with ‘undruggable’ target
MedCity News
Mon, 09/21/20 - 10:33 am
Tags:
Amgen, sotorasib, ESMO, AMG 510, non-small cell lung cancer
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Thu, 09/17/20 - 10:56 am
Tags:
Eli Lilly, Amgen, LY-CoV-55, antibody cocktail, COVID-19
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
Tags:
ESC, Amgen, Repatha, Sanofi, Regeneron, Praluent, cholesterol
A new biotech forms to revive Amgen's old heart drug
BioPharma Dive
Thu, 08/27/20 - 10:57 am
Tags:
Amgen, NewAmsterdam Pharma, obicetrapib, heart disease
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
Tue, 08/25/20 - 11:12 am
Tags:
psoriasis, AbbVie, Skyrizi, Amgen, Celgene, Otezla
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power
Fierce Biotech
Sat, 08/15/20 - 10:41 pm
Tags:
Amgen
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Mon, 08/10/20 - 10:52 pm
Tags:
Teva Pharmaceutical, migraines, Ajovy, autoinjectors, Amgen, Eli Lilly
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
MedCity News
Mon, 08/3/20 - 11:28 pm
Tags:
COVID-19, Amgen, AbbVie, Takeda, patients, clinical trials
Amgen's psoriasis pill Otezla thrives amid pandemic against injectable rivals
Fierce Pharma
Wed, 07/29/20 - 12:31 pm
Tags:
Otzela, Celgene, Amgen, psoriasis, COVID-19

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.